novel
coronaviru
sever
acut
respiratori
syndrom
caus
sever
acut
respiratori
syndrom
diseas
design
emerg
epicent
wuhan
china
decemb
global
pandem
march
confirm
countri
involv
case
global
death
report
infect
china
follow
itali
iran
republ
korea
european
union
itali
went
lockdown
countri
march
wherea
countri
unit
state
america
sever
state
declar
emerg
focal
biocontain
territori
place
lockdown
case
report
increas
alarm
rate
rapid
increas
owe
fact
widespread
test
slowli
becom
avail
howev
viru
uniqu
effici
rate
transmiss
individu
capabl
spread
other
present
ill
mimic
flulik
ill
fever
respiratori
symptom
common
present
complaint
bilater
patchi
infiltr
typic
note
comput
tomographi
ct
scan
case
occur
year
age
mild
remain
present
sever
symptom
wherea
requir
care
intens
care
unit
casefat
rate
tout
overal
although
like
overestim
lack
widespread
test
howev
death
rate
climb
age
year
nearli
half
requir
critic
care
cancer
receiv
chemotherapi
well
patient
multipl
comorbid
distinct
higher
risk
sever
ill
howev
inform
predilect
present
prognosi
solid
organ
transplant
spars
adequ
report
li
et
al
report
present
outcom
microbiolog
confirm
case
heart
transplant
detect
hubei
provinc
china
patient
appar
part
commun
least
heart
transplant
survivor
region
present
variabl
sever
diseas
one
mild
anoth
sever
manifest
requir
prolong
hospit
howev
surviv
event
import
note
clinic
present
distinct
describ
nonimmunosuppress
individu
patient
sever
diseas
present
viral
prodrom
display
typic
find
ct
scan
imag
progress
clinic
hypoxia
second
patient
present
fever
mild
ct
scan
find
screen
modal
use
china
resolut
day
laboratori
find
mirror
observ
nontranspl
patient
elev
creactiv
protein
level
lymphopenia
treatment
patient
sever
diseas
includ
withhold
baselin
immunosuppress
treat
highdos
corticosteroid
pool
immunoglobulin
infus
kitchen
sink
approach
case
also
includ
use
fluoroquinolon
along
ganciclovir
whether
therapi
use
determin
limit
report
crucial
patient
recov
discharg
without
incur
immunolog
consequ
cardiac
allograft
remain
rejectionfre
whether
transplantationrel
immunosuppress
alter
predisposit
acquir
infect
diseas
implic
modifi
better
wors
remain
uncertain
novel
coronaviru
achiev
anchor
lung
use
angiotensinconvert
receptor
pulmonari
system
via
implic
prevent
lung
inflamm
system
overpow
pulmonari
inflammatori
infiltr
emerg
express
diseas
phenotyp
unknown
heart
transplant
recipi
differenti
express
pulmonari
lower
express
may
result
less
sever
ill
similarli
antiinflammatori
effect
immunosuppress
could
diminish
clinic
express
diseas
well
specul
assumpt
requir
structur
studi
enhanc
understand
diseas
pathway
process
like
immunosuppress
patient
may
prone
acquir
viru
higher
risk
high
effici
transmiss
viru
shed
note
respiratori
specimen
also
serum
stool
viral
shed
occur
day
week
furtiv
asymptomat
carrier
individu
especi
children
fecal
shed
note
patient
without
diarrhea
signific
environment
contamin
note
includ
wash
basin
toilet
bowl
air
outlet
fan
surfac
hospit
patient
thu
prudent
advis
transplant
recipi
ardent
practic
mitig
strategi
social
distanc
sanit
hand
hygien
avoid
area
known
harbor
potenti
infect
individu
recommend
extend
care
provid
well
therapi
manifest
diseas
grave
lack
time
although
promis
horizon
although
sever
molecul
investig
remdesivir
adenosin
analog
incorpor
viral
rna
chain
result
prematur
termin
chloroquin
antimalari
drug
prevent
viral
cell
fusion
interfer
glycosyl
cellular
receptor
sarscov
appear
earli
vitro
evid
support
potenti
activ
drug
ribavirin
interferon
lopinavirritonavir
corticosteroid
use
patient
sar
middl
eastern
respiratori
syndrom
candid
investig
reason
novel
coronaviru
belong
betacoronaviru
famili
also
contain
sarscov
middl
eastern
respiratori
hyperimmun
globulin
contain
target
antibodi
deriv
plasma
recov
individu
thu
capabl
provid
passiv
immun
may
also
therapeut
ultim
control
outbreak
requir
develop
vaccin
import
area
signific
concern
transplant
clinician
involv
test
donor
decis
organ
suitabl
recent
expos
infect
implic
recoveri
organ
procur
team
need
debat
studi
rapidli
widespread
test
becom
avail
time
would
prudent
avoid
transplant
organ
donor
histori
contact
someon
risk
diagnos
well
recent
travel
area
high
densiti
infect
summari
novel
coronaviru
diseas
requir
thought
approach
prevent
mitig
time
detect
appropri
therapeut
intervent
vulner
patient
dr
aslam
report
consult
fee
merck
unrel
manuscript
dr
mehra
report
direct
conflict
pertin
develop
editori
gener
conflict
includ
consult
relationship
abbott
medtron
janssen
mesoblast
portola
bayer
nupulsecv
fineheart
leviticu
tripl
gene
dr
mehra
also
editor
chief
journal
heart
lung
transplant
paper
consid
person
opinion
author
offici
stanc
intern
societi
heart
lung
transplant
